Feb 7, 2022 | Press Releases
SAN FRANCISCO – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today announced that ClearUP® Sinus Pain Relief was named Best Sinus Pain Relief Solution of 2021 by Global Health...
Feb 7, 2022 | Press Releases
SAN FRANCISCO – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today announced that ClearUP® Sinus Pain Relief was named Best Sinus Pain Relief Solution of 2021 by Global Health...
Jan 31, 2022 | Press Releases
Growing recognition of Bioelectronic Medicine as an important new therapeutic category SAN FRANCISCO – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, was one of two companies featured in...
Jan 31, 2022 | Press Releases
Growing recognition of Bioelectronic Medicine as an important new therapeutic category SAN FRANCISCO – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, was one of two companies featured in...
Jan 19, 2022 | Press Releases
60-person clinical trial to investigate therapeutic device as an alternative to opioids following sinus surgeries SAN FRANCISCO – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today...
Nov 15, 2021 | Press Releases
MENLO PARK, Calif., Nov. 15, 2021 — Tivic Health Systems, Inc. (Nasdaq: TIVC) (“Tivic” or the “Company”), a commercial-phase bioelectronic medicine company, today announced the closing of its initial public offering of 3,000,000 shares of...
